Hunan Hansen Pharmaceutical Co., Ltd. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was CNY 254.03 million compared to CNY 250.18 million a year ago. Net income was CNY 58.26 million compared to CNY 55.07 million a year ago.

Basic earnings per share from continuing operations was CNY 0.1158 compared to CNY 0.1094 a year ago. Diluted earnings per share from continuing operations was CNY 0.1158 compared to CNY 0.1094 a year ago.